Skip to main content

Patient Selection for Surgery for Parkinson’s Disease

  • Reference work entry
Textbook of Stereotactic and Functional Neurosurgery

Abstract

The cornerstone of therapy for Parkinson’s disease (PD) is dopamine replacement with levodopa. The early years of treatment with levodopa are most predictable in obtaining a satisfactory therapeutic response. However, chronic administration can lead to problematic side effects, chiefly motor fluctuations and dyskinesias, in the majority of patients [1,2]. There has been an enormous resurgence of interest in functional surgery in PD in recent years as evidenced by the growing number of reported clinical trials in this area. Better understanding of the pathophysiology of basal ganglia dysfunction underlying PD and advancements in neuroradiological, neurosurgical and neurophysiological techniques have contributed to this trend. PD surgery involves lesioning or deep brain stimulation (DBS) of specific nuclei of the basal ganglia and cell replacement, details of which will be covered in other chapters of this book. It is worth emphasizing that surgical therapy can complement medical treatment in the more advanced cases of PD and improve quality of life [3]. A randomized study showed that DBS of the subthalamic nucleus (STN) was more effective than medical management alone in patients under 75 years of age with severe motor complications [4].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jankovic J. Motor fluctuations and dyskinesias in Parkinson’s disease: clinical manifestations. Mov Disord 2005;20 Suppl 11:S11–S16.

    Article  PubMed  Google Scholar 

  2. Jankovic J, Stacy M. Medical management of levodopa-associated motor complications in patients with Parkinson’s disease. CNS Drugs 2007;21(8):677–92.

    Article  PubMed  CAS  Google Scholar 

  3. Diamond A, Jankovic J. The effect of deep brain stimulation on quality of life in movement disorders. J Neurol Neurosurg Psychiatry 2005;76(9):1188–93.

    Article  PubMed  CAS  Google Scholar 

  4. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, et al. German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 2006;355(9):896–908.

    Article  PubMed  CAS  Google Scholar 

  5. Tan EK, Jankovic J. Movement disorder surgery: patient selection and evaluation of surgical results. In: Lozano AM, editor. Movement disorder surgery: progress and challenges, progress in neurological surgery. Basel, Switzerland: Karger; 2000. p. 78–90.

    Google Scholar 

  6. Rodriguez RL, Fernandez HH, Haq I, Okun MS. Pearls in patient selection for deep brain stimulation. Neurologist 2007;13:253–60.

    Article  PubMed  Google Scholar 

  7. Halpern C, Hurtig H, Jaggi J, Grossman M, Won M, Baltuch G. Deep brain stimulation in neurologic disorders. Parkinsonism Relat Disord 2007;13:1–16.

    Article  PubMed  Google Scholar 

  8. Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord 2007;22:2149–55.

    Article  PubMed  Google Scholar 

  9. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson’s disease. Arch Neurol 1999;56:33–9.

    Article  PubMed  CAS  Google Scholar 

  10. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2–13.

    Article  PubMed  CAS  Google Scholar 

  11. Jankovic J, Rajput AH, McDermontt MP, Perl DP. Evolution of diagnosis in early Parkinson’s disease. Arch Neurol 2000;57(3):369–72.

    Article  PubMed  CAS  Google Scholar 

  12. Kazumata K, Antonini A, Dhawan V, Moeller JR, Alterman RL, Kelly P, Sterio D, Fazzini E, Beric A, Eidelberg D. Preoperative indicators of clinical outcome following stereotaxic pallidotomy. Neurology 1997;49:1083–90.

    PubMed  CAS  Google Scholar 

  13. Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson’s disease. Mov Disord 2007;22(7):990–7.

    Article  PubMed  Google Scholar 

  14. Lyons KE, Davis JT, Pahwa R. Subthalamic nucleus stimulation in Parkinson’s disease patients intolerant to levodopa. Stereotact Funct Neurosurg 2007;85(4):169–74.

    Article  PubMed  Google Scholar 

  15. Wider C, Russmann H, Villemure JG, Robert B, Bogousslavsky J, Burkhard PR, Vingerhoets FJ. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation. Arch Neurol 2006;63(7):951–5.

    Article  PubMed  Google Scholar 

  16. Walter BL, Vitek JL. Surgical treatment for Parkinson’s disease. Lancet Neurol 2004;3(12):719–28.

    Article  PubMed  Google Scholar 

  17. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003;349(20):1925–34.

    Article  PubMed  CAS  Google Scholar 

  18. Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a meta-analysis of patient outcomes. J Neurosurg 2005;103(6):956–67.

    Article  PubMed  Google Scholar 

  19. Rodrigues JP, Walters SE, Watson P, Stell R, Mastaglia FL. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson’s disease. Mov Disord 2007;22(13):1866–70.

    Article  PubMed  Google Scholar 

  20. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for parkinsonian, essential and other types of tremor. Neurosurgery 1995;45:1743–6.

    CAS  Google Scholar 

  21. Ondo WG, Jankovic J, Schwartz K, Almaguer M, Simpson RK. Unilateral thalamic deep brain stimulation for refractory essential tremor and Parkinson’s disease tremor. Neurology 1998;51:1063–9.

    PubMed  CAS  Google Scholar 

  22. Hariz MI, Krack P, Alesch F, Augustinsson LE, Bosch A, Ekberg R, Johansson F, Johnels B, Meyerson BA, Nguyen JP, Pinter M, Pollak P, von Raison F, Rehncrona S, Speelman JD, Sydow O, Benabid AL. Multicentre European study of thalamic stimulation for Parkinsonian tremor: a 6-year follow-up. J Neurol Neurosurg Psychiatry 2008;79:694–9.

    Article  PubMed  CAS  Google Scholar 

  23. Diamond A, Shahed J, Jankovic J. The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor. J Neurol Sci 2007;260:199–203.

    Article  PubMed  Google Scholar 

  24. Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ. What clinical signs of Parkinson’s disease best reflects the nigrotriatal lesion? Ann Neurol 1997;41:58–64.

    Article  PubMed  CAS  Google Scholar 

  25. Koop MM, Andrzejewski A, Hill BC, Heit G, Bronte-Stewart HM. Improvement in a quantitative measure of bradykinesia after microelectrode recording in patients with Parkinson’s disease during deep brain stimulation surgery. Mov Disord 2006;21(5):673–8.

    Article  PubMed  Google Scholar 

  26. Vaillancourt DE, Prodoehl J, Sturman MM, Bakay RA, Metman LV, Corcos DM. Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson’s disease. Mov Disord 2006;21(1):50–8.

    Article  PubMed  Google Scholar 

  27. Desaloms JM, Krauss JK, Lai EC, Jankovic J, Grossman RG. Posteroventral medial pallidotomy for treatment of Parkinson’s disease: preoperative magnetic resonance imaging features and clinical outcome. J. Neurosurg 1998;89:194–9.

    Article  PubMed  CAS  Google Scholar 

  28. Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: a meta-analysis of ten years’ experience. Mov Disord 2007;22:1722–8.

    Article  PubMed  Google Scholar 

  29. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson’s disease: critique and recommendations. Mov Disord 2007;22:1077–92.

    Article  PubMed  Google Scholar 

  30. Rettig GM, Lai EC, Krauss JK, Grossman RG, Jankovic J. Neuropsychological evaluation of patients with Parkinson’s disease before and after pallidal surgery. In: Krauss JK, Grossman RG, Jankovic J, editors. Pallidal surgery for the treatment of Parkinson’s disease and movement disorders. Philadelphia: Lipincott-Raven; 1998. p. 211–31.

    Google Scholar 

  31. Saint-Cyr JA, Trépanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson’s disease. Brain 2000;123 (Pt 10):2091–108.

    Article  PubMed  Google Scholar 

  32. Trépanier LL, Kumar R, Lozano AM, Lang AE, Saint-Cyr JA. Neuropsychological outcome of GPi pallidotomy and GPi or STN deep brain stimulation in Parkinson’s disease. Brain Cogn 2000;42(3):324–47.

    Article  PubMed  Google Scholar 

  33. Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, Fabre N, Lotterie JA, Chaynes P, Berry I, Lazorthes Y, Rascol O. Does ageing influence deep brain stimulation outcomes in Parkinson’s disease? Mov Disord 2007;22(10):1457–63.

    Article  PubMed  Google Scholar 

  34. Contarino MF, Daniele A, Sibilia AH, Romito LM, Bentivoglio AR, Gainotti G, Albanese A. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007;78:248–52.

    Article  PubMed  CAS  Google Scholar 

  35. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Tröster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a meta-analysis. Lancet Neurol 2006;5(7):578–88.

    Article  PubMed  Google Scholar 

  36. Lang AE, Houeto JL, Krack P, Kubu C, Lyons KE, Moro E, Ondo W, Pahwa R, Poewe W, Tröster AI, Uitti R, Voon V. Deep brain stimulation: preoperative issues. Mov Disord 2006;21 Suppl 14:S171–S196.

    Article  PubMed  Google Scholar 

  37. Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff-Canning S, Lang AE, Marras C. A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson’s disease. Mov Disord 2008;23(2):297–9.

    Article  PubMed  Google Scholar 

  38. Uitti RJ, Wharen RE Jr, Turk MF, Lucas JA, Finton MJ, Graff-Radford NR, Boylan KB, Goerss SJ, Kall BA, Adler CH, Caviness JN, Atkinson EJ. Unilateral pallidotomy for Parkinson’s disease: comparison of outcome in younger versus elderly patients. Neurology 1997;49:1072–7.

    PubMed  CAS  Google Scholar 

  39. Kishore A, Turnbull IM, Snow BJ, de la Fuente-Fernandez R, Schullzer M, Mark E, Yardley S, Calne DB. Efficacy, stability and predictors of outcome of pallidotomy for Parkinson’s disease: six-month follow-up with additional 1-year observations. Brain 1997;120:729–37.

    Article  PubMed  Google Scholar 

  40. Aybek S, Gronchi-Perrin A, Berney A, Chiuvé SC, Villemure JG, Burkhard PR, Vingerhoets FJ. Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson’s disease. Mov Disord 2007;22(7):974–81.

    Article  PubMed  Google Scholar 

  41. Derost PP, Ouchchane L, Morand D, Ulla M, Llorca PM, Barget M, Debilly B, Lemaire JJ, Durif F. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007;68(17):1345–55.

    Article  PubMed  Google Scholar 

  42. Martinez-Martin P, Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Mov Disord 2007;22:757–65.

    Article  PubMed  Google Scholar 

  43. Sansur CA, Frysinger RC, Pouratian N, Fu KM, Bittl M, Oskouian RJ, Laws ER, Elias WJ. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg 2007;107(5):998–1003.

    Article  PubMed  Google Scholar 

  44. Okun MS, Foote KD. A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery. Neurologist 2004;10(5):290.

    Article  PubMed  Google Scholar 

  45. Hamani C, Stone S, Laxton A, Lozano AM. The pedunculopontine nucleus and movement disorders: anatomy and the role for deep brain stimulation. Parkinsonism Relat Disord 2007;13:S276–S280.

    Article  PubMed  Google Scholar 

  46. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 2007;130:1596–607.

    Article  PubMed  Google Scholar 

  47. Okun MS, Fernandez HH, Pedraza O, Misra M, Lyons KE, Pahwa R, Tarsy D, Scollins L, Corapi K, Friehs GM, Grace J, Romrell J, Foote KD. Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology 2004;63(1):161–3.

    PubMed  CAS  Google Scholar 

  48. Martinez-Martin P, Deuschl G. Effect of medical and surgical interventions on health-related quality of life in Parkinson’s disease. Mov Disord 2007;22:757–65.

    Article  PubMed  Google Scholar 

  49. Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of Parkinson’s disease: a cost-effectiveness analysis. Neurology 2001;57(4):663–71.

    PubMed  CAS  Google Scholar 

  50. Diamond A, Jankovic J. Quality of life and cost effectiveness of deep brain stimulation in movement disorders. In: Vitek J, Starr P, Okun M, Tarsy D, editors. Deep brain stimulation for neurological and psychiatric disorders. Current clinical neurology series. Totowa, NJ: Human Press; 2008 (in press).

    Google Scholar 

  51. Schupbach WM, Maltete D, Houeto JL, et al. Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology 2007;68:267–71.

    Article  PubMed  CAS  Google Scholar 

  52. Kenney C, Simpson R, Hunter C, Ondo W, Almaguer M, Davidson A, Jankovic J. Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg 2007;106:621–5.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The National Neuroscience Institute, Singapore and Baylor College of Medicine PD and MD Clinic are National Parkinson Foundation (NPF) International Centers of Excellence, and their support is acknowledged.

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Tan, E.K., Jankovic, J. (2009). Patient Selection for Surgery for Parkinson’s Disease. In: Lozano, A.M., Gildenberg, P.L., Tasker, R.R. (eds) Textbook of Stereotactic and Functional Neurosurgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69960-6_91

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69960-6_91

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69959-0

  • Online ISBN: 978-3-540-69960-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics